AbbVie Inc.'s Future Growth Relies on Immunology Drugs
AbbVie Inc. is looking to newer immunology drugs like Skyrizi and Rinvoq for future growth as Humira sales decline due to biosimilar competition.
News
Heroux-Devtek Reports Strong Growth in First Quarter
Canadian supplier Heroux-Devtek reports strong growth and increased profit in the first quarter, driven by civil and defense market segments.
ABN Amro Bank Reports Strong Second-Quarter Results
ABN Amro Bank reports Q2 results with net profit of €870 million and total operating income of €2.22 billion. Highlights include CET1 ratio, dividend,...
Schwab’s Custody Platform and CG Advisory Services
CG Advisory Services decides to transition assets to Axos Advisor Services while still using LPL Financial as its primary custodian.
The Growing Market for eVTOL Aircraft
Archer Aviation and Boeing settle litigation and announce investment, driving advancements in the eVTOL market. FAA grants airworthiness certificate f...
Cano Health Faces Financial Challenges
Cano Health is experiencing setbacks and plans to sell the company due to financial challenges. They are also reducing the workforce and exploring str...
UBS Ends Backstop Agreement with Swiss Government
UBS terminates its backstop arrangement with the Swiss government, signaling confidence and potential benefits in negotiating the retention of Credit...
Novo Nordisk Adjusts Supply of Wegovy Obesity Treatment in the U.S.
Novo Nordisk announces retention of Wegovy supply in the U.S. amidst high demand, leading to Ozempic shortage. Expanding capacity but restricted suppl...
Bittrex and Former CEO Settle Unregistered Securities Exchange Charges
Crypto trading platform Bittrex and its former CEO settle charges of operating an unregistered securities exchange by paying $24 million. Bittrex alle...
Rising Car Prices Bring Relief
Car prices in the US are still rising, but there is some relief as new and used car prices declined slightly. However, repair and insurance costs cont...
All Rights Reserved © 2024